Cornea Clinical Trial
Official title:
Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of topical MSC Secretome eye drops. The study will be conducted at Illinois Eye and Ear Infirmary located at University of Illinois at Chicago. The study will use anterior segment Optical Coherence Tomography (OCT)/Scheimpflug Imaging, esthesiometry, and visual analogue scale (VAS) to assess treatment tolerability.
The "Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease" study is designed to evaluate the safety and maximal tolerated dose (MTD) of topical MSC Secretome eye drops in patients with chronic ocular surface disease through a dose-escalation study under a 28-day topical application protocol, and also obtain a preliminary observation on the following: 1. Incidence of treatment emergent adverse events (TEAE) assessed at 28 days following treatment initiation 2. Proportion of patients with improved corneal epithelial barrier at 28 days compared to baseline 3. Final visual acuity, corneal epithelial thickness, corneal stromal haze, corneal sensation, and treatment tolerability The objective is to determine the dose of MSC Secretome through a first-in-human study through a dose-escalation strategy targeting a toxicity rate of 33% or less. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03674892 -
Intranasal Neurostimulation in Ameliorating Symptoms of Neuropathic Corneal Pain
|
N/A | |
| Recruiting |
NCT04439552 -
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
|
||
| Not yet recruiting |
NCT04122651 -
Toric Intraocular Lenses for Cataract Patients in the NHS
|
N/A | |
| Recruiting |
NCT03299530 -
Accuracy of Corneal Astigmatism in Different Region Modes
|
||
| Completed |
NCT04560790 -
Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis
|
N/A | |
| Recruiting |
NCT03010748 -
Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population
|
||
| Completed |
NCT02293122 -
To Investigate Agreement Between the EM-3000 and the Predicate Device Noncon Robo Pachy (F&A) (CellChek XL)
|
||
| Active, not recruiting |
NCT06389916 -
Euclid Phoenix Lens Design Trial
|
N/A | |
| Completed |
NCT06353776 -
MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular Surface
|
N/A | |
| Completed |
NCT03906513 -
Evaluation of the Efficacy of OMK2 in Recovering Corneal Neural Damage in Patients With Diabetes
|
N/A | |
| Not yet recruiting |
NCT06392607 -
Euclid Phoenix Lens Design Trial 2
|
N/A | |
| Recruiting |
NCT05232539 -
Efficiency of Intraoperative Optical Coherence Tomography (iOCT)
|
N/A | |
| Completed |
NCT02781948 -
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT
|
N/A | |
| Not yet recruiting |
NCT05345652 -
Evaluation Of Deep Anterior Lamellar Keratoplasty By Anterior Segment Ocular Coherence Tomography
|
||
| Completed |
NCT04804592 -
Investigation in Corneal Sensation and Contact Lens Wear
|
N/A | |
| Recruiting |
NCT04626583 -
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells
|
Phase 1 | |
| Recruiting |
NCT04323358 -
Agreement and Accuracy of Different Devices for Biometry Measurements in Patients With Cataract
|
N/A | |
| Completed |
NCT06277349 -
Multifocal-toric IOL Compared to Multifocal IOL Combined With Limbal Relaxing Incisions for Correction of Moderate Astigmatism During Cataract Surgery
|
N/A | |
| Withdrawn |
NCT02395952 -
Healing of Persistent Epithelial Defects
|
N/A | |
| Completed |
NCT03518775 -
Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam
|